SCHEMBL6606889

SCHEMBL6606889

CCCN(CCC)CCOc1cccc(NC(=O)c2sc(-c3ccccc3)nc2C)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.51
HPGD P15428 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MAPT P10636 3/20 0.49
GAA P10253 2/20 0.49
POLB P06746 3/20 0.49
LMNA P02545 1/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
NR1H4 Q96RI1 1/20 0.49
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MET P08581 2/20 0.48
DGAT1 O75907 1/20 0.47
EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604459 0.93 MAPT (0.52) PARP1NPC1RAB9AMAPTPOLB
SCHEMBL6602409 0.92 MAPT (0.51) PARP1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6607030 0.90 NR1H4 (0.62) NPC1ALDH1A1MAPTGAAPOLB
SCHEMBL6603227 0.89 MAPT (0.58) PARP1HPGDNPC1RAB9AALDH1A1
SCHEMBL6606883 0.87 PARP1 (0.51) PARP1HPGDNPC1RAB9AALDH1A1
SCHEMBL6602810 0.85 MCHR1 (0.54) PARP1HPGDNPC1ALDH1A1SMN1; SMN2
SCHEMBL6604034 0.83 MAPT (0.58) HPGDALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL6604450 0.80 ROCK1 (0.54) PARP1NPC1RAB9AMAPTPOLB
SCHEMBL6602401 0.80 MAPT (0.51) PARP1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL6603893 0.79 MCHR1 (0.61) PARP1HPGDNPC1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102535-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-09-29 EP disclosed
EP-1102535-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2001-05-30 EP disclosed
WO-2000006085-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO disclosed